- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
New staffers come up to speed just in time for RSNA meeting
Diagnostic Imaging has welcomed two new staffers in recent weeks. They'll be stepping into the challenging world of the RSNA meeting later this month, participating in our 12th annual webcast of the meeting.
Diagnostic Imaging has welcomed two new staffers in recent weeks. They'll be stepping into the challenging world of the RSNA meeting later this month, participating in our 12th annual webcast of the meeting.
Rebekah Moan moves into the position of deputy editor, a post formerly held by Shalmali Pal, who has become news editor for our sister publication, Oncology News International.
Moan joins us from a position at Elsevier in Washington, DC, where she was a staff writer for a newsletter covering the supplements industry.
The transition has not been as abrupt as you might imagine; her work there exposed her to clinical issues and clinical trials and should serve her well as she adapts to medical imaging.
Donna Domino has taken the position of feature editor. Before this, she worked as a freelancer and for the San Francisco Daily Journal, a daily legal newspaper.
Interestingly enough, we share a common background. In a different lifetime, I hired and supervised the starting editorial staff for the San Francisco Daily Journal. It was after leaving that publication that I found my way to medical journalism.
Domino has already started work on feature articles for Diagnostic Imaging and will treat the topics with same precision she did when she covered legal issues.
Expect to hear from them both as they step up our efforts to bring you the best clinical and practice coverage of radiology.
-John C. Hayes is editor of Diagnostic Imaging.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
